OMER Stock Analysis: Buy, Sell, or Hold?
OMER - Omeros Corporation
$10.48
0.15 (1.45%)
▲
5d:
+12.33%
30d:
-12.37%
90d:
-1.69%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Smart Money Accumulation
None View Scanner →
Strength: 7.0/10
Get Alerted When OMER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OMER shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: OMER shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: OMER is currently trading at $10.48, which is considered fair relative to its 30-day fair value range of $9.66 to $11.81. From a valuation perspective, the stock is trading at a discount (Forward PE: -349.3) compared to its historical average (78.7). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OMER is in a strong uptrend. The price is approaching resistance at $10.60. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: OMER has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.00 (+281.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OMER is in a strong uptrend. The price is approaching resistance at $10.60. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: OMER has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.00 (+281.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$9.66 -
$11.81
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
88.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 281.7% below Wall St target ($40.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$9.66 -
$11.81
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$6.70
Resistance Level
$10.60
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-349.33
Wall Street Target
$40.00
(+281.7%)
Revenue Growth (YoY)
14.9%
Profit Margin
871.0%
PE vs Historical
-349.3 vs 78.7
CHEAP
Share & Embed Analysis
Last updated: June 24, 2026 9:22 AM ET
Data refreshes hourly during market hours. Next update: 10:22 AM
Data refreshes hourly during market hours. Next update: 10:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OMER showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
David J Borges
SELL
30000 shares
2026-01-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 65 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 60 BUY |
Advanced OMER Option Strategies
Professional options setups generated by AI based on today's OMER price and gamma walls.
